Whole Human Blood for Transfusion from Japan
Whole human blood collected from donors, anticoagulated, and prepared for direct transfusion into patients experiencing acute blood loss or anemia. It falls under HTS 3002.90.52.10 as whole human blood intended for therapeutic uses without separation into components like plasma or platelets.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Pharmaceuticals: patented pharma from JP/EU/KR/CH/LI — 15% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Obtain FDA biologics license and import permit; provide donor screening and testing certificates to verify safety and traceability
• Maintain strict cold chain (2-6°C) with validated shipping containers and temperature logs to prevent spoilage during transit
• Avoid common pitfalls like incomplete chain-of-custody documentation, which can lead to quarantine or destruction by customs